Skip to main content
Equibles

JENNISON ASSOCIATES LLC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 53417 NEW YORK, NY
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$104,710,445
-$15,395,052 QoQ
Shares Held
1,663,655
-2.8% QoQ
Ownership
3.79%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#8
of 256 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JENNISON ASSOCIATES LLC holds $3,808,452,552 across 46 Biotechnology names. TARS ranks #9 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,998,530 $1,489,459,806
2 ARGX
Argenx SE
 226,200 $209,861,574
3 ROIV
Roivant Sciences Ltd.
 4,481,964 $158,616,705
4 PVLA
Palvella Therapeutics, Inc.
 960,619 $146,801,794
5 PTGX
Protagonist Therapeutics, Inc
 1,151,681 $141,173,056
6 SRRK
Scholar Rock Holding Corp
 2,358,587 $129,722,285
7 IMVT
Immunovant, Inc.
 3,310,238 $127,543,470
8 ARQT
Arcutis Biotherapeutics, Inc.
 4,219,058 $110,623,700

All Filings in TARS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $104,710,445 1,663,655
2026-03-31 $120,105,497 1,712,124
2025-12-31 $182,598,049 2,230,069
2025-09-30 $154,790,189 2,604,580
2025-06-30 $99,978,598 2,467,998
2025-03-31 $128,046,916 2,492,640
2024-12-31 $138,432,308 2,500,132
2024-09-30 $71,653,495 2,178,580
2024-06-30 $40,222,811 1,479,868
2024-03-31 $48,379,595 1,330,938